LifeVantage (NASDAQ:LFVN) Lifted to “Hold” at ValuEngine

ValuEngine upgraded shares of LifeVantage (NASDAQ:LFVN) from a sell rating to a hold rating in a research note issued to investors on Tuesday morning, ValuEngine reports.

LifeVantage stock traded up $0.05 during trading on Tuesday, reaching $15.25. The company had a trading volume of 95,122 shares, compared to its average volume of 115,132. The firm’s 50-day simple moving average is $14.57 and its 200 day simple moving average is $12.78. LifeVantage has a 1-year low of $10.62 and a 1-year high of $17.08. The firm has a market capitalization of $213.88 million, a PE ratio of 25.85 and a beta of 0.64. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.09 and a current ratio of 1.67.

LifeVantage (NASDAQ:LFVN) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.13 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.12 by $0.01. The company had revenue of $56.23 million during the quarter. LifeVantage had a net margin of 3.65% and a return on equity of 38.13%. Analysts anticipate that LifeVantage will post 0.67 EPS for the current year.

In related news, CEO Darren Jay Jensen sold 4,500 shares of the company’s stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $14.13, for a total transaction of $63,585.00. Following the completion of the transaction, the chief executive officer now owns 411,470 shares in the company, valued at approximately $5,814,071.10. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 6.80% of the stock is owned by insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in shares of LifeVantage by 237.4% in the second quarter. BlackRock Inc. now owns 891,174 shares of the company’s stock worth $11,568,000 after acquiring an additional 627,070 shares during the last quarter. Wedge Capital Management L L P NC acquired a new stake in LifeVantage during the 2nd quarter worth $1,151,000. Jacobs Levy Equity Management Inc. boosted its stake in LifeVantage by 214.7% during the 2nd quarter. Jacobs Levy Equity Management Inc. now owns 117,545 shares of the company’s stock worth $1,526,000 after purchasing an additional 80,199 shares during the last quarter. State Street Corp grew its holdings in shares of LifeVantage by 43.3% during the third quarter. State Street Corp now owns 237,192 shares of the company’s stock worth $3,250,000 after buying an additional 71,657 shares in the last quarter. Finally, Acadian Asset Management LLC grew its holdings in shares of LifeVantage by 14.7% during the second quarter. Acadian Asset Management LLC now owns 418,294 shares of the company’s stock worth $5,430,000 after buying an additional 53,545 shares in the last quarter. Institutional investors and hedge funds own 45.15% of the company’s stock.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.

Featured Article: Diversification in Investing

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.